3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
NETWORK
1
Study Type
Observational
1
Sponsor
Conditions
Locally Advanced Head and Neck Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Stomach Neoplasms
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Malnutrition
1
Malabsorption Syndromes
1
Hyperphagia
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Cachexia
1
Body Weight
1
Anus Neoplasms
1
Interventions
Bevacizumab
2
trifluridine tipiracil drug combination
1
gadolinium ethoxybenzyl DTPA
1
gadobutrol
1
encorafenib
1
durvalumab
1
Urine Specimen Collection
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Oxaliplatin
1
Oviposition
1
Nivolumab
1
Levoleucovorin
1
Leucovorin
1
Irinotecan
1
Immunotherapy
1
IDRX-42
1
Hydromorphone
1
Fluorouracil
1
Fentanyl
1
Drug Therapy
1
Drainage
1
Dietary Supplements
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Bupivacaine
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Dietary Supplements
×
1 year
×
Clear all
NCT07035132
2025-10-07
NORMA
Outcomes'10
Enrolling by invitation
132 enrolled